Survanta™

Survanta™

Therapeutic Segment: Lung Surfactant

Generic Name: Beractant

Indication:

For prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants.
Significantly reduces the incidence of RDS, mortality due to RDS and air leak complications.

Available as:

Suspension
  • 25MG